Friday 6 November 2026 Export WGS’s income statement to Excel — free account

GeneDx Holdings Corp.

GeneDx Holdings Corp.’s revenue for fiscal 2025 (year ended December 2025) was $427.5 million, up 40.0% from fiscal 2024.

Revenue: +11.4%
EPS: −257.9%
Free cash flow: −585.6%
Total debt: +87.4%

Quarter to June 2026, against a year earlier

61.83 2.53 −3.93%

Follow WGS

Alert me

Market cap: $1.9B
P/E: 0.0×
Fwd P/E: −20.6×
Dividend yield: —
F-score: 6/9
Altman Z: 7.80
Beneish M: −2.36
Dividend safety: n/a

Overview

GeneDx Holdings Corp. (WGS) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, GeneDx Holdings Corp. (WGS) trades at a P/B ratio of 7.9×. Over the past ten years it has ranged from 0.0× (December 2020) to 16.5× (November 2025); the current reading is higher than 75% of that period. That is above the Diagnostics & Research industry median of 3.4× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/WGS/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="GeneDx Holdings Corp. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/WGS/metrics/pb-ratio">GeneDx Holdings Corp. (WGS) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	12.1×	43.43%
FY2024	8.4×	2,893.82%
FY2023	0.3×	2,391.15%
FY2022	0.0×	(69.95%)
FY2021	0.0×	(97.36%)
FY2020	1.4×	—
FY2019	0.0×	—

Period	P/B ratio	Change
Jun 2026	8.4×	12.65%
Mar 2026	7.4×	(38.67%)
Dec 2025	12.1×	13.86%
Sep 2025	10.6×	11.52%
19 more quarters	Free account

Against its own ten years

Low 0.0× High 16.5×

Ten-year median 0.6×

Current reading's percentile 75

Company	P/B ratio
FRNM Freenome, Inc compare	n/m
OPK OPKO Health, Inc. compare	1.2×
VCYT Veracyte, Inc. compare	1.4×
CSTL Castle Biosciences, Inc. compare	2.2×
NEO NeoGenomics, Inc. compare	2.7×
PSNL Personalis, Inc. compare	7.9×
WGS GeneDx Holdings Corp.	7.9×
CDNA CareDx, Inc. compare	8.6×
ADPT Adaptive Biotechnologies Corporation compare	23.5×
Diagnostics & Research industry median	3.4×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

GeneDx Holdings Corp. (WGS) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on WGS

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on WGS

Stockrow Weekly